Retiro De Equipo (Recall) de Swann Ganz continuous flow catheters (CCO)

Según L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en France que fue producido por Edwards Lifesciences.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Notas adicionales en la data
  • Acción
    On 10/05/2010, the company Edwards Lifesciences has withdrawn from the market batches of the medical device called "Swann Ganz continuous flow catheters (CCO)", reference 744HF75 lot 58615355 and reference 746HF8 lot 58612699 as a result of an electronic problem at the connector of the thermal filament of the catheter. This defect causes impossible measurements of cardiac output and the display of an error message on the alertness monitor. This recall, similar to that carried out in February 200, is implemented following the highlighting by the industrialist of new lots concerned .. The company Edwards Lifesciences directly warned the recipients of the incriminated lots with the help of the message attached (14/05/2010) (24 KB) validated by the Afssaps. This information is addressed to the directors and correspondents of materiovigilance for diffusion if necessary to the services concerned. The relevant European Competent Authorities are informed of this measure by the manufacturer.